Search results for "interquartile range"

showing 10 items of 263 documents

Impact of asymmetric dimethylarginine on mortality after acute myocardial infarction.

2008

Objective— Asymmetrical dimethylarginine (ADMA) is an endogenous competitive inhibitor of nitric oxide (NO) synthases. From a prospective cohort of patients with acute myocardial infarction (MI), we aimed to analyze the predictive value of circulating ADMA concentrations on prognosis. Methods and Results— Blood samples from 249 consecutive patients hospitalized for acute MI <24 hours were taken on admission. Serum levels of ADMA and its stereoisomer, symmetrical dimethylarginine (SDMA), were determined using high-performance liquid chromatography. The independent predictors of ADMA were glomerular filtration rate, female sex, and SDMA ( R 2 =0. 25). Baseline ADMA levels were higher in p…

Malemedicine.medical_specialtyMyocardial InfarctionRenal functionArginineNitric oxideCohort Studieschemistry.chemical_compoundInterquartile rangePredictive Value of TestsInternal medicinemedicineHumansMyocardial infarctionProspective StudiesProspective cohort studyAgedAged 80 and overbusiness.industryHazard ratioConfoundingMiddle Agedmedicine.diseasePrognosisSurgerychemistryCardiologyRegression AnalysisFemaleCardiology and Cardiovascular MedicineAsymmetric dimethylargininebusinessBiomarkersFollow-Up StudiesArteriosclerosis, thrombosis, and vascular biology
researchProduct

iScore for predicting institutional care after ischemic stroke: a population-based study.

2015

Background We assessed whether the iScore could predict the need for poststroke institutional care. Methods Patients with acute ischemic stroke living in Dijon, France, were recorded between 2006 and 2011, using a population-based stroke registry. The iScore was calculated for each patient. A logistic regression model was used to assess the performance of the iScore for predicting the need for placement in a care institution. The discrimination and calibration of the model were assessed using the c statistic and the Hosmer–Lemeshow goodness-of-fit test, respectively. Results Of the 1199 patients recorded, 124 were excluded because of early death and 95 because of missing for variables inclu…

Malemedicine.medical_specialtyPopulationLogistic regressionRehabilitation CentersRisk AssessmentPatient Care PlanningBrain IschemiaDecision Support TechniquesInterquartile rangePredictive Value of TestsRisk FactorsEpidemiologyMedicineHumansRegistrieseducationStrokeStatisticAgedAged 80 and overeducation.field_of_studyFramingham Risk Scorebusiness.industryRehabilitationMiddle Agedmedicine.diseasePrognosisConfidence intervalPatient DischargeNursing HomesStrokeLogistic ModelsEmergency medicinePhysical therapySurgeryFemaleNeurology (clinical)FranceCardiology and Cardiovascular MedicinebusinessJournal of stroke and cerebrovascular diseases : the official journal of National Stroke Association
researchProduct

Influence of Preexisting Cognitive Impairment on Clinical Severity of Ischemic Stroke: The Dijon Stroke Registry.

2020

Background and Purpose— The ongoing ageing population is associated with an increasing number of patients with stroke who have preexisting cognitive impairment. This study aimed to evaluate clinical severity in patients with ischemic stroke according to prestroke cognitive status. Methods— Patients with ischemic stroke were prospectively identified among residents of Dijon, France using a population-based registry (2013–2017). Prestroke cognitive status (no impairment, mild cognitive impairment [MCI], or dementia) was recorded, and severity at stroke onset was measured using the National Institutes of Health Stroke Scale (NIHSS) score. Association between prestroke cognitive status and sev…

Malemedicine.medical_specialtyPopulationSeverity of Illness IndexInterquartile rangeInternal medicineEpidemiologymedicineDementiaHumansCognitive DysfunctionProspective StudiesRegistrieseducationCognitive impairmentStrokeAgedAdvanced and Specialized NursingAged 80 and overeducation.field_of_studybusiness.industryOdds ratiomedicine.diseaseStrokeIschemic strokeFemaleNeurology (clinical)FranceCardiology and Cardiovascular MedicinebusinessStroke
researchProduct

Early effects of empagliflozin on exercise tolerance in patients with heart failure: A pilot study

2018

BackgroundSodium-glucose linked transporter 2 inhibition recently emerged as a promising therapy for reducing the risk of heart failure (HF) in patients with type 2 diabetes mellitus (T2DM). However, there is a lack of data endorsing its role in symptomatic HF patients. We sought to evaluate the short-term effects of empagliflozin on maximal exercise capacity in these patients. HypothesisWe postulate tretament with empagliflozin may improve functional capacity in patients with T2DM and established HF. MethodsNineteen T2DM patients with symptomatic HF were prospectively included and underwent cardiopulmonary exercise testing before and 30days after initiation of empagliflozin therapy. A mixe…

Malemedicine.medical_specialtyTime FactorsClinical InvestigationsEmpagliflozinRenal functionPilot ProjectsWalk Test030204 cardiovascular system & hematology03 medical and health sciencesExercise Capacity0302 clinical medicineOxygen ConsumptionQuality of lifeGlucosidesInterquartile rangeInternal medicineEmpagliflozinmedicineHumansHypoglycemic Agents030212 general & internal medicineProspective StudiesBenzhydryl CompoundsProspective cohort studyAgedHeart FailureExercise Tolerancebusiness.industryRepeated measures designType 2 Diabetes MellitusGeneral MedicineRecovery of FunctionMiddle AgedEmpagliflozin Exercise Capacity Heart Failuremedicine.diseaseTreatment OutcomeDiabetes Mellitus Type 2Heart failureCardiologyQuality of LifeFemaleCardiology and Cardiovascular MedicinebusinessPulmonary Ventilation
researchProduct

Renal Impairment Is Associated with Intracerebral Hemorrhage after Mechanical Thrombectomy in Vertebrobasilar Stroke

2018

<b><i>Background and Purpose:</i></b> Renal dysfunction (RD) is overall associated with unfavorable functional outcome and higher risk of mortality after acute ischemic stroke. Associations between RD and outcome in patients with acute vertebrobasilar stroke treated with thrombectomy have not been evaluated so far. <b><i>Materials and Methods:</i></b> Consecutive patients with vertebrobasilar stroke treated with mechanical thrombectomy between October 2010 and July 2017 at our center were analyzed. RD was defined as glomerular filtration rate (GFR) < 60 mL/min/1.73 m<sup>2</sup> at admission. Endpoints were (I) poor clinic…

Malemedicine.medical_specialtyTime FactorsDatabases FactualStroke severityRenal function030204 cardiovascular system & hematologyKidneyRisk Assessment03 medical and health sciences0302 clinical medicineRisk FactorsVertebrobasilar strokeInterquartile rangeInternal medicineVertebrobasilar InsufficiencyRisk of mortalitymedicineHumansIn patientcardiovascular diseasesAgedCerebral HemorrhageThrombectomyAged 80 and overIntracerebral hemorrhagebusiness.industryMiddle Agedmedicine.diseaseStrokeMechanical thrombectomyTreatment OutcomeNeurologyCardiologyFemaleKidney DiseasesNeurology (clinical)Cardiology and Cardiovascular Medicinebusiness030217 neurology & neurosurgeryGlomerular Filtration RateCerebrovascular Diseases
researchProduct

Quality of life and functional limitations after pulmonary embolism and its prognostic relevance

2019

Abstract Background While the importance of patients’ quality of life (QoL) in chronic cardiac or pulmonary disease is uncontroversial, the burden of an acute pulmonary embolism (PE) on QoL has received little attention thus far. Objectives We aimed to validate the German PEmb‐QoL questionnaire, identify associations between QoL and clinical/functional parameters, and investigate the prognostic relevance of QoL for long‐term survival in survivors of an acute PE episode. Patients/Methods Patients were invited for a clinical follow‐up visit including assessment of QoL using the German PEmb‐QoL questionnaire 6 months after an objectively confirmed PE at a single center. Internal consistency re…

Malemedicine.medical_specialtyTime FactorsPsychometricsPsychometricsHealth Status030204 cardiovascular system & hematologySingle Center03 medical and health sciences0302 clinical medicineCost of IllnessQuality of lifePredictive Value of TestsRisk FactorsInterquartile rangeGermanySurveys and QuestionnairesInternal medicinemedicineHumansProspective StudiesSurvivorsProspective cohort studyDepression (differential diagnoses)Agedbusiness.industryReproducibility of ResultsOriginal ArticlesHematologyMiddle AgedPrognosismedicine.diseasehumanities3. Good healthPulmonary embolismTHROMBOSISDyspneaPredictive value of testsQuality of LifeFemaleOriginal ArticleSymptom AssessmentPulmonary Embolismbusiness
researchProduct

Serum Neprilysin and Recurrent Admissions in Patients With Heart Failure

2017

Background Our aim was to evaluate the association between the soluble form of neprilysin ( sNEP ) levels and long‐term all‐cause, cardiovascular, and acute heart failure ( AHF ) recurrent admissions in an ambulatory cohort of patients with heart failure. sNEP has emerged as a new biomarker with promising implications for prognosis and therapy in patients with heart failure. Reducing the recurrent admission rate of heart failure patients has become an important target of public health planning strategies. Methods and Results We measured sNEP levels in 1021 consecutive ambulatory heart failure patients. End points were the number of all‐cause, cardiovascular, and AHF hospitalizations during…

Malemedicine.medical_specialtyTime Factorsmedicine.drug_class030204 cardiovascular system & hematologyPatient Readmissionneprilysin03 medical and health sciences0302 clinical medicinePredictive Value of TestsRisk FactorsInterquartile rangeCause of DeathInternal medicineNatriuretic Peptide BrainmedicineNatriuretic peptideHumans030212 general & internal medicineAgedOriginal ResearchAged 80 and overHeart Failurereadmissionbusiness.industryIncidenceMiddle AgedPrognosismedicine.diseasePeptide FragmentsConfidence intervalUp-RegulationQuartileSpainHeart failureCohortAmbulatoryCardiologyBiomarker (medicine)FemaleNeprilysinCardiology and Cardiovascular MedicinebusinessReadmissionBiomarkers
researchProduct

Mortality after cardioverter-defibrillator replacement: Results of the DECODE survival score index

2020

Background Device replacement is the ideal time to reassess health care goals regarding continuing implantable cardioverter-defibrillator (ICD) therapy. Only few data are available on the decision making at this time. Objectives The goals of this study were to identify factors associated with poor prognosis at the time of ICD replacement and to develop a prognostic index able to stratify those patients at risk of dying early. Methods DEtect long-term COmplications after implantable cardioverter-DEfibrillator replacement (DECODE) was a prospective, single-arm, multicenter cohort study aimed at estimating long-term complications in a large population of patients who underwent ICD/cardiac resy…

Malemedicine.medical_specialtyTime Factorsmedicine.medical_treatmentPopulationReplacementCardiac resynchronization therapy030204 cardiovascular system & hematologyPrognostic indexImplantable cardioverter-defibrillatorNOElectrocardiography03 medical and health sciences0302 clinical medicineInterquartile rangePhysiology (medical)Internal medicinemedicineHumansProspective Studies030212 general & internal medicineeducationShared decision makingAgedOutcomeAged 80 and overHeart Failureeducation.field_of_studyIschemic cardiomyopathybusiness.industryProportional hazards modelMiddle AgedImplantable cardioverter-defibrillatorDefibrillators ImplantableSurvival RateDeath Sudden CardiacItalyFemaleCardiology and Cardiovascular MedicinebusinessDecision Making SharedBody mass indexFollow-Up StudiesCohort study
researchProduct

Visual outcomes and complications of congenital cataract surgery

2019

Corresponding author at: Department of Ophthalmology, 14, rue Paul-Gaffarel, 21000 Dijon, France. This work is issued from the oral presentation during the 123rd congress of the French Ophthalmological Society.; International audience; PURPOSE: To describe the visual results and postoperative complications of congenital cataract surgeries performed between 2005 and 2016. METHODS: A retrospective consecutive case series of congenital cataract surgeries was carried out at the Dijon University Hospital in France. Intraocular lens implantation was primary or secondary according to age. Pre- and post-operative assessment was performed through ophthalmologic consultations with orthoptic measureme…

Malemedicine.medical_specialtyVisual acuitygenetic structuresvisual acuitymedicine.medical_treatmentintraocular lensIntraocular lensCataract ExtractionCataract03 medical and health sciences0302 clinical medicineLens Implantation IntraocularCataractsInterquartile rangepostoperative complicationsHumansMedicine[SDV.MHEP.OS]Life Sciences [q-bio]/Human health and pathology/Sensory OrgansRetrospective StudiesLenses Intraocularbusiness.industryInfantPostoperative complicationConsecutive case seriesCataract surgerymedicine.diseaseeye diseases3. Good healthSurgeryBilateral CataractsOphthalmologyTreatment Outcomecongenital cataractChild Preschool030221 ophthalmology & optometryFemaleFrancesense organsmedicine.symptombusiness[SDV.MHEP]Life Sciences [q-bio]/Human health and pathology
researchProduct

Walking Speed as an Alternative Measure of Functional Status in Patients with Lumbar Spinal Stenosis

2019

Objective The main objective was to compare estimated walking perimeter (WP) and actual WP during a free walking test (6-minute walk test [6MWT]) in patients with lumbar spinal stenosis (LSS). The second objective was to describe the correlation between measured gait parameters and functional parameters. Methods This was a single-center prospective study including 38 patients with symptomatic LSS (23 men, 15 women; mean age, 69.3 ± 7.9 years). The intervention was the 6MWT. For the main outcome measure, patients were first asked to verbally estimate their WP. Then, WP was evaluated using a 6MWT at a self-selected speed. In the absence of need to stop, and if a distance of 500 m was not reac…

Malemedicine.medical_specialty[SDV]Life Sciences [q-bio]Walk TestPerimeter03 medical and health sciencesSpinal Stenosis0302 clinical medicineQuality of lifeInterquartile rangeBack painmedicineHumansProspective StudiesAgedLumbar Vertebraebusiness.industryLumbar spinal stenosismedicine.diseaseGaitWalking SpeedOswestry Disability IndexPreferred walking speed030220 oncology & carcinogenesisPhysical therapyFemaleSurgeryNeurology (clinical)medicine.symptombusiness030217 neurology & neurosurgeryWorld Neurosurgery
researchProduct